FDA committee rejects two IQOS MRTP claims, approves one
25th January 2018 - News analysis |
Agency’s science committee agrees that PMI product decreases exposure to dangerous chemicals, but won’t accept broader claims of long-term risk reduction
Agency’s science committee agrees that PMI product decreases exposure to dangerous chemicals, but won’t accept broader claims of long-term risk reduction
PMI has responded forcefully after a Swiss research team claimed its iQOS heat-not-burn system released “the same harmful constituents of conventional cigarette smoke”
The launch of PMI’s heated tobacco device iQOS in South Africa has had a positive reaction even from potential competitors, who hope it will increase general awareness of alternatives to combustible cigarettes.
Philip Morris International (PMI) has submitted its iQOS heat-not-burn system for approval by the U.S. Food and Drug Administration (FDA).
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis.